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Aims. Our aim was to identify the factors that made the specimens inadequate and nondiagnostic in endoscopic ultrasound-
guided ﬁne-needle aspiration(EUS-FNA) biopsyofsuspected submucosaltumors(SMTs).Methods.FromAugust2001to October
2009, 47 consecutive patients with subepithelial hypoechoic tumors originating in the fourth sonographic layer of the gastric wall
suspected as GIST by standard EUS in Chiba University hospital underwent EUS-FNA for histologic diagnosis. We evaluated
patient age, sex, location of lesion, size, pattern of growth in a stomach, and pattern of echography retrospectively. We deﬁned a
case of gaining no material or an insuﬃcient material for immunohistologicaldiagnosis as nondiagnostic.Results.T h ed i a g n o s t i c
yield ofEUS-FNA for thediagnosisofgastric SMTswas 74.5%.Multivariate logisticregression analysisidentiﬁed thatageofunder
60 years (compared with patients older than 60 years: odds ratio [OR] = 11.91, 95% conﬁdence interval [CI] = 1.761–80.48)
and location of SMT at lower third area (compared with upper or middle third area: OR = 10.62, 95% CI = 1.290–87.42) were
t h ep r e d i c t i v ef a c t o r sf o ri n a d e q u a t et i s s u ey i e l di nE U S - F N A .Conclusions. The factors associated with inadequate tissue yield in
EUS-FNA were younger age and the location of lesion at lower third area in stomach.
1.Introduction
Gastrointestinal stromal tumors (GISTs) are the most com-
mon mesenchymal tumors of the gastrointestinal (GI) tract.
GISTs are frequently discovered by chance on endoscopy
performed and are characterized by a bulging of the GI wall
with normal, overlying mucosa. GISTs were described in
1983 as tumors in the GI tract and mesentery, characterized
by a speciﬁc histological and immunohistochemical pattern
[1]. Since GIST is now considered as potentially malignant,
all GISTs may need to be resected, even small lesions [2].
Diﬀerentiating these lesions from benign submucosal lesions
such as leiomyomas or schwannomas is crucial. Butstandard
endoscopic biopsy specimens are usually nondiagnostic
because the mucosa overlying the submucosal lesion such as
GIST is normal.
Endoscopic ultrasonography (EUS),enabling intramural
scanning oftheGI tract, has beenreported to beuseful in the
diagnosis of submucosal tumor (SMT) and in diﬀerentiating
SMT from extraluminal lesions [3–5]. EUS is not only
capable of characterizing lesions of the GI tract and adjacent
structures, but it is also capable of guiding the ﬁne-needle
aspiration under real-time ultrasound using a through-the-
scope needle aspiration system [6, 7].
Endoscopic ultrasound-guided ﬁne-needle aspiration
biopsy (EUS-FNA)is considered tobe a reliable and accurate
method for the evaluation of submucosal lesions in the
GI tract. With this method, it has been reported that
the accuracy in gastrointestinal diseases such as SMT was
high (38–100%), compared to conventional EUS and that
complicationsincludingbleedingand infection were rare (0–
2.6%) [8, 9].
Therefore, SMT is a suitable target of EUS-FNA. EUS-
FNA has been well documented as providing cytologic
material for the diagnosis of malignancy, but large studies
assessing its utility have mainly looked at its use in sampling
lymph nodes, pancreas, and extraintestinal masses [10–
16]. Although studies to date evaluating the diagnostic2 ISRN Gastroenterology
yield of EUS-FNA for the diagnosis of GISTs have been
reported, those studies analyzed a small number of patients
or discussed about general GI tract other than stomach
[17–25]. In addition, there were few studies about factors
associated with inadequate tissue yield.
The aim of this study was to determine the diagnostic
yield of EUS-FNAof suspected GISTs inthe stomach and the
factors that made specimens inadequate and nondiagnostic.
2.PatientsandMethods
2.1.Patients. When wecouldnotobtaintissuefromSMTsby
the usual endoscopic biopsy, we conducted EUS-FNA. From
August 2001 to October 2009, 47 consecutive patients with
submucosal hypoechoic tumors originating in the fourth
sonographic layer of the gastric wall suspected as GIST by
standard EUS underwent EUS-FNA for histologic diagnosis
at Chiba University Hospital. This study was carried out
only at one institute, the Chiba University Hospital, and
was approved by the committee of Chiba University ethical.
There were 24 males and 23 females, and the mean age was
60.4 years (range 39–81 years).
2.2. EUS-FNA. Standard EUS was performed using 12 or
15MHz ultrasound catheter probe SP-701 (FUJIFILM,
Japan). The cases diagnosed as lipoma or cyst by EUS
were excluded. EUS-FNA was performed on outpatients
having SMT-suspected GIST (>2cmorif<2cm,increasing
in size), with the patient under conscious sedation (Flu-
nitrazepam, 0.4–1.0mg i.v.), using a conventional convex
scanner echoendoscope. This procedure was performed by
three endosonographers. The echoendoscope was connected
to an ultrasound scanner ProSound SSD-4000 (ALOKA,
Japan). The equipment used consisted of GF-UC240P scope
(Olympus, Japan) and 22G NA-200H aspiration needles
(Olympus, Japan) or EchoTip Ultrasound needles (Wilson-
Cook, USA). Color ﬂow and the Doppler sonography were
performed to exclude intervening vascular structures and
to select a vessel-free needle track to avoid puncturing
vessels. After puncture, the inner needle was pulled out.
With the vacuum pressure maintained using the connected
20mL syringe, the aspiration needle was moved within each
tumor in various directions more than 10 times. The saline-
containing aspirated material was transferred to a Petri dish,
and examined macroscopically.
2.3. Immunohistochemistry. Immunoperoxidase stains were
subsequently performed on the cell block and representative
histologicsectionsofthetumorusing commercially available
antibodies against c-kit(CD117),CD34,S-100, and smooth-
muscle actin. Diagnosis of GIST was made when pathologic
examination showed spindle or epithelioid cells that stained
positive for c-kit.
2.4. Factors Associated with Inadequate Tissue in EUS-FNA.
We deﬁned a case of gaining a suﬃcient material for
immunohistological diagnosis as diagnostic and calculated
a diagnostic yield. We divided patients into two groups,
diagnostic and nondiagnostic group and evaluated patient
U (upper third) M (middle third) L (lower third)
Anterior wall
Posterior wall
Greater curvature
Lesser curvature
Figure 1: Lesions in the stomach of gastric SMT. Open circles rep-
resent diagnostic cases and closed circles represent nondiagnostic
cases by EUS-FNA.
Table 1: Technical results of EUS-FNA (n = 47).
Results
Gaining an adequate
specimen
for immunohistological
diagnosis
35/47 (74.5%)
Complications (Bleeding) 0/47 (0%)
Accuracy∗ 13/13 (100%)
∗Compared to the pathological ﬁndings using the specimens by surgery.
age, sex, location of lesion, size long axis (in millimeters),
pattern of growth in stomach, and pattern of echography.
As for the gastric neoplasm group, the location of the lesion
in stomach was classiﬁed into three areas: upper third (U),
middle third (M), and lower third (L).
2.5. Ethics. This study was carried out only at one institute,
Chiba University Hospital and was approved by the commit-
tee of Chiba University ethical. Written informed consent
was obtained from all the patients in accordance with the
Declaration of Helsinki.
2.6. Statistical Analysis. Data are shown as the mean ± SD.
The diﬀerence between two groups was tested by the Stu-
dent’s t-test. Comparisons of proportions were performed
using the chi-square test. P<. 05 was considered statistically
signiﬁcant. Toevaluatetheclinicalparameters forinadequate
tissue yield in EUS-FNA for gastric SMT, logistic regression
analysis was performed. SPSS software version 16.0 (SPSS
Inc., Chicago, Ill, USA) was used for statistical analysis.
3.Results
3.1. Patients and the Results of EUS-FNA. A total of 47
patients who had undergone EUS-FNA of gastric fourth
layer subepithelial lesions were identiﬁed. The mean age
of patients was 60.4. Of the total of 47 cases, 35 (74.5%)
had adequate FNA materials for cytological and histologicalISRN Gastroenterology 3
(a) (b)
(c) (d)
Figure 2:EUS-FNA procedure. Case:62years old, female,tumor size20mm,area M instomach.(a) Endoscopyshowingsubmucosallesion
in the stomach,(b) EUS showingsubmucosalhypoechoic tumor with continuity to the proper musclelayer, (c) the hypoechoic massshown
on EUS was punctured under real-time EUS guidance (EUS-FNA), and (d) cell block specimen from a GIST revealing brown staining,
positive for c-kit immunoperoxidase stain.
examination. And 12 (25.5%) were judged as inadequate.
The diagnostic yield was 74.5%. Figure 1 shows the location
in the stomach (anterior wall, posterior wall, greater cur-
vature, and lesser curvature) of each case (Figure 1). Final
diagnoses after EUS-FNA were GIST (n = 27), leiomyoma
(n = 2), schwannoma (n = 1), aberrant pancreas (n =
2), malignant lymphoma (n = 1), adenocarcinoma (n =
1), inﬂammatory granuloma (n = 1), and nondiagnostic
(n = 12 ). Surgical resection in our hospital was performed
in 13 of 27 patients that were diagnosed having GIST
in EUS-FNA. To compare the pathologic ﬁndings in the
tissues from EUS-FNA with the specimen obtained from
surgical resection, the accuracy was 100%. No complications
occurred (Table 1). EUS-FNA with immunohistochemical
analysis was asafe andaccuratemethodinthepretherapeutic
diagnosis of SMT. A case with adequate specimen obtained
f r o mE U S - F N Aw a ss h o w ni nF i g u r e2.
3.2. Factors Associated with Inadequate Tissue Yield. There
were 35 patients with diagnostic FNA cytologic ﬁndings and
on the other hand, 12 patients without diagnostic cytologic
ﬁndings. The clinical background of the patients was shown
in Table 2. There was no statistical signiﬁcance in sex, size,
patternofgrowth ina stomach, and patternof echography in
the patients with and without diagnostic cytological ﬁnding.
Ontheotherhand,thediagnosticyieldofEUS-FNAcytology
for the diagnosis of SMT was inﬂuenced by age and location.
Patients were signiﬁcantly younger in the nondiagnostic
group, with a mean age of 49.0 compared with 64.4. The
lesions signiﬁcantly located in L area more than U or M
area in the nondiagnostic group (Table 2). The thresholds of
age and size of SMT were the average value in the patients.
Univariate analysis identiﬁed that age of under 60 years and
location of SMT at L area were independent factors for
inadequate tissue yield in EUS-FNA. Multivariate logistic
regression analysis identiﬁed that age of under 60 years
(comparedwithpatientsolderthan60years: oddsratio(OR)
= 11.91, 95% conﬁdence interval (CI) = 1.761–80.48) and
location of SMT at L area (compared with U or M area: OR
= 10.62, 95% CI = 1.290–87.42) were the predictive factors
for inadequate tissue yield in EUS-FNA (Table 3).
4.Discussion
GISTs are the most commonly identiﬁed intramural, sub-
mucosal mass in the upper GI tract. These masses are
frequently found on endoscopyperformed for otherreasons,
butpatients may also present with abdominal pain, bleeding,
or symptoms of mass eﬀect [25]. It is well recognized that all
GISTs have some degree of malignant potential [1, 2]. Even
small localized GISTs may demonstrate malignant features
on histologic examination or biologic behavior. However,
the mucosal surface of SMT is usually normal, and the
biopsy examination by conventional forceps at endoscopy
was frequently negative, which showed the diﬃculty in
achieving the material of SMT.4 ISRN Gastroenterology
Table 2: Factors associated with the diagnostic yield of EUS-FNA.
All Diagnostic Nondiagnostic
Factors (n = 47) (n = 35) (n = 12) P value
Age (years old) 60.4 ± 13.3 64.4 ± 11.3 49.0 ± 12.3 <.001∗
20∼29 1 (2.1%) 0 (0%) 1 (8.3%)
30∼39 3 (6.4%) 1 (2.9%) 2 (16.7%)
40∼49 5 (10.6%) 2 (5.7%) 3 (25.0%)
50∼59 11 (23.4%) 8 (22.9%) 3 (25.0%)
60∼69 17 (36.2%) 14 (40.0%) 3 (25.0%)
70∼79 6 (12.8%) 6 (17.1%) 0 (0%)
80∼89 4 (8.5%) 4 (11.4%) 0 (0%)
Sex (M/F) 24/23 19/16 5/7 N.S.∗∗
Tumor location
U 26 (55.3%) 22 (62.9%) 4 (33.3%) N.S.∗∗
M 15 (31.9%) 11 (31.4%) 4 (33.3%) N.S.∗∗
L 6 (12.8%) 2 (5.7%) 4 (33.3%) .013 ∗∗
Tumor size (mm) 29.0 ± 11.2 29.3 ± 12.4 28.3 ± 6.7 N.S.∗
10∼19 5 (10.6%) 4 (11.4%) 1 (8.3%)
20∼29 20 (42.6%) 14 (40%) 5 (41.7%)
30∼39 14 (29.8%) 9 (25.7%) 5 (41.7%)
40∼49 7 (14.9%) 6 (17.1%) 1 (8.3%)
50∼ 1 ( 2.1%) 1 (2.9%) 0 (0%)
Pattern of growth (No.[%]) N.S.∗∗
intragastric 34 (72.4%) 23 (65.7%) 11 (32.4%)
extragastric 5 (10.6%) 5 (14.3%) 0 (0%)
mixed 8 (17.0%) 7 (20.0%) 1 (12.5%)
Pattern of echography (No.[%]) N.S.∗∗
homo 20 (42.6%) 13 (37.1%) 7 (35.0%)
hetero 27 (57.4%) 22 (62.9%) 5 (18.5%)
∗Student t-test.
∗∗Chi-square test.
Table 3: Logistic regression analysis of factors associated with nondiagnosticyield of EUS-FNA.
Univariate Analysis Multivariate Analysis
Hazard Ratio (95% conﬁdence interval) P value Hazard Ratio (95% conﬁdence interval) P value
Sex (Male) 0.564 (0.149–2.137) .564
Age (<60 years) 9.167 (1.720–48.85) .009 11.91 (1.761–80.48) .011
Location (Lower) 8.000 (1.238–51.69) .029 10.62 (1.290–87.42) .028
Tumor Size (>29mm) 0.564 (0.149–2.137) .564
Pattern of growth (Intragastric) 2.956 (0.732–11.93) .128
Pattern of echography (Homo) 5.739 (0.660–49.91) .113
The thresholds of age and tumor size were their average values.
EUS is eﬀective for a diagnosis of these lesions. Lipomas,
cysts and submucosal varices have typical features that allow
accurate diagnosis based solely on the data gathered from
endoscopy and EUS imaging [3, 4, 19]. Additionally, EUS-
FNA is more eﬀective for a diagnosis of SMT. In the study of
23 patients with GISTs, it is reported that EUS features alone
had a diagnostic accuracy of 77% versus an accuracy of 91%
obtained from immunohistochemical analysis from a FNA
specimen [18].
The majority of reports on EUS-FNA have focused on
pancreatic lesions and lymphadenopathy. Few reports have
speciﬁcally investigated the use of EUS-FNA in evaluating
intramural and extramural structures of the GI tract [24].
Andoetal.retrospectivelyexamined49patientswithsubmu-
cosal tumors originating from the fourth sonographic layer.
In 4 patients, specimens were inadequate for histopathologic
diagnosis, giving a diagnostic yield of 91.8% (45/49) [18].
Okubo et al. examined 18 patients with GIST undergoing
both EUS-FNA and surgical resection and calculated a diag-
nostic yield and sensitivity of 78.0% (14/18) [22]. Akahoshi
et al. studied 53 subepithelial gastric tumors. Diagnostic
specimens were obtained in 42/51 (82%) patients [17]. InISRN Gastroenterology 5
this study, the collection rate of adequate specimens from
a gastric subepithelial hypoechoic tumor with continuity to
proper muscle layer was 74.5%. No major complications
were encountered. A reason for lower diagnostic yield in
our study is that we deﬁned, as diagnostic, EUS-FNA
procedure only in a case of gaining a suﬃcient material
for immunohistological diagnosis, which is essential for a
diagnosis of GIST [1].
The predictivefactors for inadequateEUS-FNAin gastric
SMT were age and location in the stomach. Against our
expectations, in younger patients, the rate of achieving
adequate quantity of specimens was lower than that in older
patients. The numbers of larger SMT in younger and older
patients were 7/20 (35.0%) and 15/27 (55.6%), respectively,
which showed no signiﬁcant diﬀerence (P = .16, chi-square
test). We speculated that it might be caused by the diﬃculty
tokeepthe good positionand view inEUS-FNAwhich could
be easily inﬂuenced by a stronger pharyngeal reﬂex of young
patients compared to older patients. The location of SMT in
the stomach was shown in Figure 1. In fact, SMTs at L area
were diﬃcult to obtain adequate samples. We think it was
more diﬃcult to keep a scope stably at the L area, because
we need to keep pushing a scope only at the L area, and the
situation is unstable.
This study has several important strengths. This is one of
a few studies about the factors that inﬂuence the diagnostic
yield of EUS-FNA for SMT. Other study reports that the
sensitivity of EUS-FNA is inﬂuenced by size, organ, shape,
and layer of origin [25].
But the report is not limited to gastric SMTs, and the
number is lesser in this study.
Additionally, because there were no study about the fac-
tors associated with inadequate tissue yield, this is precious,
especially in the point of the analysis of each location in a
stomach.
In conclusion, the diagnostic yield of EUS-FNA for the
diagnosis of gastric SMT is 74.5%, and the factors associated
with inadequate tissue yield in EUS-FNAfor gastric SMT are
younger age and location of lesion at L area in a stomach.
Considering these factors may bring the improvement of
accuracy in EUS-FNA.
Abbreviations
EUS-FNA: Endoscopic ultrasound-guided ﬁne-needle
aspiration biopsy
SMT: Submucosal tumor
GIST: Gastrointestinal stromal tumor
CI: Conﬁdence interval.
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